Advertisement
Screener

RHYTHM PHARMACEUTICALS, INC. (RYTM) Net Margin

RHYTHM PHARMACEUTICALS, INC. (RYTM) Net Margin

  • 2026-06-30: Net Margin -69.19%.
  • 2026-03-31: Net Margin -92.56%.
  • 2025-12-31: Net Margin -82.97%.
  • 2025-09-30: Net Margin -103.13%.

Complete source-backed net margin history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-69.19%
2026-03-31-92.56%
2025-12-31-82.97%
2025-09-30-103.13%
2025-06-30-96.14%
2025-03-31-151.35%
2024-12-31-103.50%
2024-09-30-131.25%
2024-06-30-110.95%
2024-03-31-544.43%
2023-12-31-171.80%
2023-09-30-196.25%
2023-06-30-242.98%
2023-03-31-454.96%
2022-12-31-483.42%
2022-09-30-953.80%
2022-06-30-496.37%
2022-03-31-3522.30%
2021-12-31-2359.16%
2021-09-30-3415.08%
2021-06-30-12915.69%
2021-03-31125000.00%

Annual Net Margin

DateNet Margin
2025-12-31-103.57%
2024-12-31-200.27%
2023-12-31-238.52%
2022-12-31-766.22%
2021-12-31-2207.10%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alkermes plc. (ALKS)$6.844B132.74
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60